AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MEDOVEX, LLC a Delaware limited liability company Dated as of April 2, 2021 AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MEDOVEX, LLC a Delaware limited liability companyLimited Liability Company Agreement • April 8th, 2021 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Florida
Contract Type FiledApril 8th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of Medovex, LLC (this “Agreement”), is effective as of April 2, 2021 (the “Effective Date”), by and among Medovex, LLC, a Delaware limited liability company (the “Company”), the Members and the Persons that in the future acquire Equity Securities in the Company.
INTELLECTUAL PROPERTY LICENSE AGREEMENTIntellectual Property License Agreement • April 8th, 2021 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Florida
Contract Type FiledApril 8th, 2021 Company Industry JurisdictionThis Intellectual Property License Agreement (“Agreement”) is made, entered into, and effective as of April 2, 2021 (the “Effective Date”) by and between Medovex Corp., a Nevada corporation having an address at 201 E. Kennedy Blvd, Suite 700, Tampa, Florida 33602 (“Licensor”) and Medovex, LLC, a Delaware limited liability company (“Licensee”).